Management of MSI-H/dMMR Metastatic Colorectal Cancer
7:00 – 8:00 PM EST
Event Type: Zoom Webinar
Event Landscape
This interactive webinar will provide practical, evidence-based strategies to help you deliver the best care for patients with MSI-H/dMMR metastatic colorectal cancer. Hear directly from leading experts and gain insights you can apply in your practice immediately.
What you Will Learn
- Explore recent advances in immunotherapy-based treatment options for MSI-H/dMMR metastatic colorectal cancer.
- Apply data from the CheckMate-8HW trial to guide the development of individualized treatment plans.
- Examine best practices in patient management to optimize clinical outcomes.
- Identify, recognize, and manage immune-mediated adverse events effectively.
Why Attend?
This interactive webinar will provide practical, evidence-based strategies to help you deliver the best care for patients with MSI-H/dMMR metastatic colorectal cancer. Hear directly from leading experts and gain insights you can apply in your practice immediately.
Event Co-Chairs
Dr. Eric Chen,
MD, PhD, FRCPC
Dr. Eric Chen is a staff physician at the Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada, and a professor at Faculty of Medicine, University of Toronto. His clinical activities focus on the treatment of gastrointestinal cancers. He participates in clinical trials evaluating new agents and treatment strategies for gastrointestinal cancers.
Dr. Mustapha Tehfe,
MD, MSc
I graduated in medicine from the Lebanese University and in hemato-oncology from the University of Balamand in Lebanon. I completed a 3-year fellowship at the Claudius Regaud Institute in Toulouse, France. I have been a researcher at the CRCHUM since 2009, and I have a master’s degree in oncogenesis from Paul Sabatier University in Toulouse.
This session is part of a multi-channel educational series aimed at improving clinical confidence and patient care in the era of ALK inhibitor therapy
This program has been made possible through unrestricted support from BMS